Correlation Between Aerovate Therapeutics and Solid Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Solid Biosciences LLC, you can compare the effects of market volatilities on Aerovate Therapeutics and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Solid Biosciences.

Diversification Opportunities for Aerovate Therapeutics and Solid Biosciences

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aerovate and Solid is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Solid Biosciences go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Solid Biosciences

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.87 times less return on investment than Solid Biosciences. But when comparing it to its historical volatility, Aerovate Therapeutics is 1.03 times less risky than Solid Biosciences. It trades about 0.01 of its potential returns per unit of risk. Solid Biosciences LLC is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  630.00  in Solid Biosciences LLC on September 2, 2024 and sell it today you would lose (60.00) from holding Solid Biosciences LLC or give up 9.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Solid Biosciences LLC

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Solid Biosciences LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Solid Biosciences LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Aerovate Therapeutics and Solid Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Solid Biosciences

The main advantage of trading using opposite Aerovate Therapeutics and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.
The idea behind Aerovate Therapeutics and Solid Biosciences LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stocks Directory
Find actively traded stocks across global markets